Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 243 results:
Συντάκτης [ Τίτλος![(Asc)](https://www.med.auth.gr/sites/all/modules/biblio/misc/arrow-asc.png)
Φίλτρα: Συντάκτης is Karagiannis, Asterios [Clear All Filters]
Health benefits of the Mediterranean Diet: an update of research over the last 5 years..
Angiology. 66(4), 304-18.
(2015). Has the time come for a new definition of microalbuminuria?.
Curr Vasc Pharmacol. 6(2), 81-3.
(2008). Gonadal dysfunction in systemic diseases..
Eur J Endocrinol. 152(4), 501-13.
(2005).
(2019).
(2015). Free Cortisol Is a More Accurate Marker for Adrenal Function and Does Not Correlate with Renal Function in Cirrhosis..
Dig Dis Sci. 64(6), 1686-1694.
(2019). Focal nodular hyperplasia of the liver in a patient with primary aldosteronism..
J Gastroenterol Hepatol. 19(4), 480-1.
(2004). Fibrinogen, hematocrit, and platelets in mild kidney dysfunction and the role of uric acid: an Italian male population study..
Clin Appl Thromb Hemost. 18(1), 113-4.
(2012). Ezetimibe and low density lipoprotein subfractions: an ongoing debate..
Curr Med Res Opin. 27(3), 693-5.
(2011). Exploring the Management of Statin Intolerant Patients: 2016 and Beyond..
Curr Vasc Pharmacol. 14(6), 523-533.
(2016). Excess volume removal following lung ultrasound evaluation decreases central blood pressure and pulse wave velocity in hemodialysis patients: a LUST sub-study..
J Nephrol. 33(6), 1289-1300.
(2020). Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?.
Expert Opin Ther Targets. 12(7), 809-20.
(2008). Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism..
Nephrol Dial Transplant. 22(1), 293.
(2007). Endothelial function, arterial stiffness and lipid lowering drugs..
Expert Opin Ther Targets. 11(9), 1143-60.
(2007). Endocrine hypertension: diagnosis and management of a complex clinical entity..
Curr Vasc Pharmacol. 8(5), 646-60.
(2010). Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance..
J Clin Lipidol. 6(1), 93.
(2012). Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study..
Curr Med Res Opin. 24(6), 1593-9.
(2008). Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia..
Am J Cardiol. 101(11), 1679-80.
(2008). Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness..
J Am Soc Hypertens. 8(2), 74-82.
(2014). Effects of lipid-lowering agents on inflammation, haemostasis and blood pressure..
Curr Pharm Des. 20(40), 6306-13.
(2014). Effects of lipid lowering drugs on arterial stiffness. One more way to reduce cardiovascular risk?.
Curr Vasc Pharmacol.
(2019). Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients..
Am J Cardiol. 101(4), 483-5.
(2008). The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes..
Lancet Diabetes Endocrinol. 2(5), 362-3.
(2014). Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review..
Curr Med Res Opin. 29(10), 1263-74.
(2013).
(2014).